Identification of C2orf18, termed ANT2BP (ANT2-binding protein), as one of the key molecules involved in pancreatic carcinogenesis.

Abstract:

:Pancreatic ductal adenocarcinoma (PDAC) shows one of the worst mortality rates among the common malignancies, and the great majority of PDAC patients are diagnosed at an advanced stage where no effective therapy is presently available. Hence, identification of novel molecular targets and development of molecular therapy for PDAC are urgently required. Through our genome-wide gene expression profiles of microdissected PDAC cells, we here identified a novel gene C2orf18 as a molecular target for PDAC treatment. Transcriptional and immunohistochemical analysis validated its overexpression in PDAC cells and limited expression in normal adult organs. Knockdown of C2orf18 by small-interfering RNA in PDAC cell lines resulted in induction of apoptosis and suppression of cancer cell growth, suggesting its essential role in maintaining viability of PDAC cells. We showed that C2orf18 was localized in the mitochondria and it could interact with adenine nucleotide translocase 2 (ANT2), which is involved in maintenance of the mitochondrial membrane potential and energy homeostasis, and was indicated some roles in apoptosis. These findings implicated that C2orf18, termed ANT2-binding protein (ANT2BP), might serve as a candidate molecular target for pancreatic cancer therapy.

journal_name

Cancer Sci

journal_title

Cancer science

authors

Kashiwaya K,Hosokawa M,Eguchi H,Ohigashi H,Ishikawa O,Shinomura Y,Nakamura Y,Nakagawa H

doi

10.1111/j.1349-7006.2008.01058.x

subject

Has Abstract

pub_date

2009-03-01 00:00:00

pages

457-64

issue

3

eissn

1347-9032

issn

1349-7006

pii

CAS1058

journal_volume

100

pub_type

杂志文章
  • Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells.

    abstract::The transcriptional factor hypoxia-inducible factor-1 (HIF-1) plays an important role in solid tumor cell growth and survival. Overexpression of HIF-1alpha has been demonstrated in many human tumors and predicts a poor response to chemoradiotherapy. We examined the HIF-1alpha-induced survival pathways in human oral sq...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2005.00065.x

    authors: Sasabe E,Tatemoto Y,Li D,Yamamoto T,Osaki T

    更新日期:2005-07-01 00:00:00

  • Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors.

    abstract::L-type amino acid transporter 1 (LAT1), overexpressed on the membrane of various tumor cells, is a potential target for tumor-targeting therapy. This study aimed to develop a LAT1-mediated chemotherapeutic agent. We screened doxorubicin modified by seven different large neutral amino acids. The aspartate-modified doxo...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.12672

    authors: Wu W,Dong Y,Gao J,Gong M,Zhang X,Kong W,Li Y,Zeng Y,Si D,Wei Z,Ci X,Jiang L,Li W,Li Q,Yi X,Liu C

    更新日期:2015-06-01 00:00:00

  • Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.

    abstract::RNA-binding proteins (RBPs) play fundamental roles in the RNA life cycle. The aberrant expression of RBPs is often observed in human disease, including cancer. In this study, we screened for the expression levels of 1542 human RBPs in The Cancer Genome Atlas liver hepatocellular carcinoma samples and found 92 consiste...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.13209

    authors: Li T,Li S,Chen D,Chen B,Yu T,Zhao F,Wang Q,Yao M,Huang S,Chen Z,He X

    更新日期:2017-05-01 00:00:00

  • Metabolome analysis for pancreatic cancer risk in nested case-control study: Japan Public Health Center-based prospective Study.

    abstract::Discovery of a high-risk group for pancreatic cancer is important for prevention of pancreatic cancer. The present study was conducted as a nested case-control study including 170 pancreatic cancer cases and 340 matched controls of our population-based cohort study involving 30 239 subjects who answered a baseline que...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.13573

    authors: Nakagawa T,Kobayashi T,Nishiumi S,Hidaka A,Yamaji T,Sawada N,Hirata Y,Yamanaka K,Azuma T,Goto A,Shimazu T,Inoue M,Iwasaki M,Yoshida M,Tsugane S

    更新日期:2018-05-01 00:00:00

  • Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.

    abstract::Biliary tract cancer (BTC) arises from biliary epithelial cells (BECs) and includes intrahepatic cholangiocarcinoma (IHCC), gallbladder cancer (GC), and extrahepatic cholangiocarcinoma (EHCC). Although frequent KRAS mutations and epigenetic changes at the INK4A/ARF locus have been identified, the molecular pathogenesi...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.14703

    authors: Kasuga A,Semba T,Sato R,Nobusue H,Sugihara E,Takaishi H,Kanai T,Saya H,Arima Y

    更新日期:2020-10-17 00:00:00

  • Reviewing the current classification of inhibitor of growth family proteins.

    abstract::Inhibitor of growth (ING) family proteins have been defined as candidate tumor suppressors for more than a decade. Recent emerging results using siRNA and knockout mice are expanding the previous understanding of this protein family. The results of ING1 knockout mouse experiments revealed that ING1 has a protective ef...

    journal_title:Cancer science

    pub_type: 杂志文章,评审

    doi:10.1111/j.1349-7006.2009.01183.x

    authors: Unoki M,Kumamoto K,Takenoshita S,Harris CC

    更新日期:2009-07-01 00:00:00

  • Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.

    abstract::Anaplastic large cell lymphoma (ALCL) and Hodgkin lymphoma (HL) express CD30 at high levels, but stimulation of this molecule has been reported to induce contradictory effects. To elucidate the molecular mechanism of CD30-mediated apoptosis of ALCL, we compared the gene expression profiles of t(2;5)(p23;q35)-positive ...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2005.00078.x

    authors: Nishikori M,Ohno H,Haga H,Uchiyama T

    更新日期:2005-08-01 00:00:00

  • Evaluation of antitumor effects following tumor necrosis factor-α gene delivery using nanobubbles and ultrasound.

    abstract::The antitumor effects of tumor necrosis factor (TNF-α) were evaluated following transfection of TNF-α plasmid DNA into solid mouse tumors using the nanobubbles (NBs) and ultrasound (US) gene delivery system. Murine breast carcinoma (EMT6) cells expressing luciferase (1 × 10(6) cells) were injected intradermally into t...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2011.02056.x

    authors: Horie S,Watanabe Y,Ono M,Mori S,Kodama T

    更新日期:2011-11-01 00:00:00

  • Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer.

    abstract::Uniform antibody microdistribution throughout tumor nodules is crucial for antibody-targeted therapy, because non-uniform microdistribution leads to suboptimal therapeutic effect, a commonly observed limitation of therapeutic antibodies. Herein, we evaluated the microdistribution of different doses of intraperitoneall...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2009.01423.x

    authors: Kosaka N,Ogawa M,Paik DS,Paik CH,Choyke PL,Kobayashi H

    更新日期:2010-03-01 00:00:00

  • Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors.

    abstract::Tumor angiogenesis inhibition is one of the most potent strategies in cancer chemotherapy. From past clinical studies, inhibition of the vascular endothelial growth factor pathway successfully treats malignant tumors. However, vascular endothelial growth factor inhibitors alone cannot cure tumors. Moreover, resistance...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.13741

    authors: Shimazu K,Inoue M,Sugiyama S,Fukuda K,Yoshida T,Taguchi D,Uehara Y,Kuriyama S,Tanaka M,Miura M,Nanjyo H,Iwabuchi Y,Shibata H

    更新日期:2018-10-01 00:00:00

  • Cross-species difference in telomeric function of tankyrase 1.

    abstract::Telomeres protect chromosome ends from being recognized as DNA double-strand breaks. Telomere shortening, which occurs due to incomplete replication of DNA termini, limits the proliferative capacity of human somatic cells and contributes as a barrier to carcinogenesis. In most human cancer cells, telomerase maintains ...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2007.00462.x

    authors: Muramatsu Y,Ohishi T,Sakamoto M,Tsuruo T,Seimiya H

    更新日期:2007-06-01 00:00:00

  • Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles.

    abstract::This study aims to identify postoperative recurrence patterns of pancreatic cancer with different molecular profiles, which provides evidence for personalized target volumes of adjuvant radiotherapy. Patients with pathologically confirmed resectable pancreatic ductal adenocarcinoma were included. Recurrences were trea...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.14486

    authors: Zhu X,Cao Y,Ju X,Zhao X,Jiang L,Ye Y,Shen Y,Cao F,Qing S,Zhang H

    更新日期:2020-05-17 00:00:00

  • Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis.

    abstract::Lipoxygenases induce malignant tumor progression and lipoxygenase inhibitors have been considered as promising anti-tumor agents. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is one of the most promising candidates for new cancer therapeutics. Combined treatment with nordihydroguaiaretic acid (NDGA)...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2007.00559.x

    authors: Yoshida T,Shiraishi T,Horinaka M,Nakata S,Yasuda T,Goda AE,Wakada M,Mizutani Y,Miki T,Nishikawa A,Sakai T

    更新日期:2007-09-01 00:00:00

  • Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.

    abstract::Neuroblastoma (NB) is the most common extracranial solid tumor that originates from multipotent neural crest cells. NB cell populations that express embryonic stem cell-associated genes have been identified and shown to retain a multipotent phenotype. However, whether somatic reprogramming of NB cells can produce simi...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.12746

    authors: Islam SM,Suenaga Y,Takatori A,Ueda Y,Kaneko Y,Kawana H,Itami M,Ohira M,Yokoi S,Nakagawara A

    更新日期:2015-10-01 00:00:00

  • Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.

    abstract::Estrogen receptor (ER) status is an essential determinant of clinical and biological behavior of human breast cancers. While ER-positive breast cancers respond well to adjuvant hormone therapy, ER-negative tumors are generally resistant. To date, no attempts have succeeded in finding molecular markers for classifying ...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2004.tb02206.x

    authors: Nagahata T,Onda M,Emi M,Nagai H,Tsumagari K,Fujimoto T,Hirano A,Sato T,Nishikawa K,Akiyama F,Sakamoto G,Kasumi F,Miki Y,Tanaka T,Tsunoda T

    更新日期:2004-03-01 00:00:00

  • Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes.

    abstract::Estrogen receptor (ER)-positive breast cancer is a distinct subpopulation of breast cancer exhibiting a high response rate to endocrine therapy. However, not all ER-positive patients respond to the therapy, and a subgrouping of ER-positive patients based on the physiology of estrogen signaling is expected to be useful...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2004.tb03239.x

    authors: Yoshida N,Omoto Y,Inoue A,Eguchi H,Kobayashi Y,Kurosumi M,Saji S,Suemasu K,Okazaki T,Nakachi K,Fujita T,Hayashi S

    更新日期:2004-06-01 00:00:00

  • Evaluation of the antitumor mechanism of antibody-drug conjugates against tissue factor in stroma-rich allograft models.

    abstract::Tissue factor (TF) is known to be overexpressed in various cancers including pancreatic cancer. The upregulation of TF expression has been observed not only in tumor cells, but also in tumor stromal cells. Because of the potential of TF as a delivery target, several studies investigated the effectiveness of Ab-drug co...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.14146

    authors: Tsumura R,Manabe S,Takashima H,Koga Y,Yasunaga M,Matsumura Y

    更新日期:2019-10-01 00:00:00

  • Nucleophosmin: a versatile molecule associated with hematological malignancies.

    abstract::Nucleophosmin (NPM) is a nucleolar phosphoprotein that plays multiple roles in ribosome assembly and transport, cytoplasmic-nuclear trafficking, centrosome duplication and regulation of p53. In hematological malignancies, the NPM1 gene is frequently involved in chromosomal translocation, mutation and deletion. The NPM...

    journal_title:Cancer science

    pub_type: 杂志文章,评审

    doi:10.1111/j.1349-7006.2006.00270.x

    authors: Naoe T,Suzuki T,Kiyoi H,Urano T

    更新日期:2006-10-01 00:00:00

  • Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.

    abstract::TLR-9 agonists are immunostimulating agents that have antitumor effects in animal models. A phase I trial was conducted to define the safety profile of subcutaneous injections, combined with intrathecally administration of CpG-28, a TRL 9 agonist, in patients with neoplastic meningitis (NM). Cohorts of 3-6 patients wi...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.12724

    authors: Ursu R,Taillibert S,Banissi C,Vicaut E,Bailon O,Le Rhun E,Guillamo JS,Psimaras D,Tibi A,Sacko A,Marantidou A,Belin C,Carpentier AF

    更新日期:2015-09-01 00:00:00

  • Small compound bigelovin exerts inhibitory effects and triggers proteolysis of E2F1 in multiple myeloma cells.

    abstract::Multiple myeloma (MM) is a currently incurable blood cancer. Here we tested the effects of a small compound bigelovin on MM cells, and reported that it caused cell cycle arrest and subsequently induced apoptosis. Bigelovin triggered proteolysis of E2F1, which could be inhibited by caspase inhibitor. To investigate the...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.12295

    authors: Liu JL,Zeng GZ,Liu XL,Liu YQ,Hu ZG,Liu Y,Tan NH,Zhou GB

    更新日期:2013-12-01 00:00:00

  • Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether.

    abstract::With limited treatment options, intraperitoneal spread of ovarian cancer is a common problem leading to high morbidity. Intraperitoneal photodynamic therapy combined with debulking surgery to treat residual disease is an alternative choice for clinicians. Hematoporphyrin monomethyl ether (HMME) is a promising second-g...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2007.00628.x

    authors: Song K,Kong B,Li L,Yang Q,Wei Y,Qu X

    更新日期:2007-12-01 00:00:00

  • Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer.

    abstract::This phase 1, open-label, dose-escalation study was conducted to determine the safety, tolerability, pharmacokinetics and preliminary efficacy of veliparib with carboplatin and weekly paclitaxel in Japanese women with newly diagnosed, advanced ovarian cancer. Patients received veliparib at 100 or 150 mg b.i.d. on days...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.13381

    authors: Nishio S,Takekuma M,Takeuchi S,Kawano K,Tsuda N,Tasaki K,Takahashi N,Abe M,Tanaka A,Nagasawa T,Shoji T,Xiong H,Nuthalapati S,Leahy T,Hashiba H,Kiriyama T,Komarnitsky P,Hirashima Y,Ushijima K

    更新日期:2017-11-01 00:00:00

  • Expression of Ret finger protein correlates with outcomes in endometrial cancer.

    abstract::Ret finger protein (RFP) is a nuclear protein with transcriptional repressive activity that is highly expressed in a variety of human and rodent tumor cell lines. We examined the expression of RFP in human endometrial cancer and assessed its clinical significance. Formalin-fixed, paraffin-embedded sections from endome...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2009.01278.x

    authors: Tsukamoto H,Kato T,Enomoto A,Nakamura N,Shimono Y,Jijiwa M,Asai N,Murakumo Y,Shibata K,Kikkawa F,Takahashi M

    更新日期:2009-10-01 00:00:00

  • Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.

    abstract::Nasal natural killer (NK)/T-cell lymphoma (NKTCL) and chronic active Epstein-Barr virus infection (CAEBV) are relatively frequent, especially in Asia, and are poor in prognosis. Both diseases are proliferative diseases of NK/T cells that show highly complicated karyotypes, suggesting the involvement of chromosomal ins...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2006.00226.x

    authors: Liu A,Takakuwa T,Luo WJ,Fujita S,Aozasa K

    更新日期:2006-07-01 00:00:00

  • Possible enhancing effects of atrazine on growth of 7,12-dimethylbenz(a) anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats.

    abstract::Atrazine, one of the most commonly used herbicides in the world, has been reported to have endocrine disrupting effects in vivo. In the present experiment, influence of dietary atrazine on the late promotion/progression stage of mammary carcinogenesis in ovariectomized female Sprague-Dawley rats was examined after a s...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2005.00008.x

    authors: Ueda M,Imai T,Takizawa T,Onodera H,Mitsumori K,Matsui T,Hirose M

    更新日期:2005-01-01 00:00:00

  • New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion.

    abstract::We present an acute promyelocytic leukemia (APL) patient with two subtypes of IRF2BP2-RARA, in which the IRF2BP2 gene showed completely new breakpoints. Bone marrow examination revealed morphologic features indicative of APL. However, promyelocytic leukemia-RARA fusion was not detected. A paired-end mRNA sequencing fo...

    journal_title:Cancer science

    pub_type:

    doi:10.1111/cas.12970

    authors: Shimomura Y,Mitsui H,Yamashita Y,Kamae T,Kanai A,Matsui H,Ishibashi T,Tanimura A,Shibayama H,Oritani K,Kuyama J,Kanakura Y

    更新日期:2016-08-01 00:00:00

  • Associations of Japanese food intake with survival of stomach and colorectal cancer: A prospective patient cohort study.

    abstract::Dietary factors may affect the prognosis of digestive tract cancer, but evidence has been sparse. We investigated the association between pretreatment intake of 6 Japanese foods (including soy food, miso [soybean paste] soup and seaweed) and the risk of death among patients with histologically confirmed major digestiv...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.14459

    authors: Minami Y,Kanemura S,Oikawa T,Suzuki S,Hasegawa Y,Nishino Y,Fujiya T,Miura K

    更新日期:2020-07-01 00:00:00

  • Epidemiology of nonmelanoma skin cancer in Japan: Occupational type, lifestyle, and family history of cancer.

    abstract::Skin cancer is the most frequently diagnosed cancer in the fair-skinned population. In recent years, the incidence of nonmelanoma skin cancer (NMSC) has been increasing worldwide. However, there is no epidemiological study on skin cancer in the Asian population. A prospective cohort study including 140 420 participant...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.14619

    authors: Cai H,Sobue T,Kitamura T,Sawada N,Iwasaki M,Shimazu T,Tsugane S

    更新日期:2020-11-01 00:00:00

  • Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells.

    abstract::Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI) are effective for non-small cell lung cancers (NSCLC) with EGFR-activating mutations. However, most responders develop resistance. Efatutazone, a novel peroxisome proliferator-activated receptor gamma (PPARγ) agonist, is currently under clinical ev...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/cas.12411

    authors: Serizawa M,Murakami H,Watanabe M,Takahashi T,Yamamoto N,Koh Y

    更新日期:2014-06-01 00:00:00

  • Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.

    abstract::Drug resistance is a major concern in the successful treatment of ovarian cancer. In the present study we report a combinational drug regime using arsenic trioxide (ATO) and cisplatin (CDDP) to increase therapeutic potentiality in ovarian cancer cells. ATO-mediated growth inhibition and apoptosis in human suspension o...

    journal_title:Cancer science

    pub_type: 杂志文章

    doi:10.1111/j.1349-7006.2009.01340.x

    authors: Zhang N,Wu ZM,McGowan E,Shi J,Hong ZB,Ding CW,Xia P,Di W

    更新日期:2009-12-01 00:00:00